TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Monte Rosa Therapeutics
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Monte Rosa Therapeutics announced CEO Markus Warmuth will participate in multiple healthcare investor conferences in November and December 2025, presenting the company's molecular glue degrader (MGD) research and developments.

Insights
BACpS   positive

First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends


GLUE   positive

Company is actively presenting at multiple investor conferences, showcasing ongoing research and potential for growth in biotechnology, particularly in molecular glue degrader medicines